1. Home
  2. NBIX vs ALSN Comparison

NBIX vs ALSN Comparison

Compare NBIX & ALSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBIX
  • ALSN
  • Stock Information
  • Founded
  • NBIX 1992
  • ALSN 1915
  • Country
  • NBIX United States
  • ALSN United States
  • Employees
  • NBIX 1448
  • ALSN N/A
  • Industry
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • ALSN Auto Parts:O.E.M.
  • Sector
  • NBIX Health Care
  • ALSN Consumer Discretionary
  • Exchange
  • NBIX Nasdaq
  • ALSN Nasdaq
  • Market Cap
  • NBIX 11.8B
  • ALSN 10.2B
  • IPO Year
  • NBIX 1996
  • ALSN 2012
  • Fundamental
  • Price
  • NBIX $117.44
  • ALSN $116.11
  • Analyst Decision
  • NBIX Buy
  • ALSN Hold
  • Analyst Count
  • NBIX 24
  • ALSN 8
  • Target Price
  • NBIX $163.91
  • ALSN $92.25
  • AVG Volume (30 Days)
  • NBIX 1.0M
  • ALSN 582.9K
  • Earning Date
  • NBIX 10-30-2024
  • ALSN 10-29-2024
  • Dividend Yield
  • NBIX N/A
  • ALSN 0.86%
  • EPS Growth
  • NBIX 97.40
  • ALSN 16.28
  • EPS
  • NBIX 3.73
  • ALSN 8.18
  • Revenue
  • NBIX $2,242,800,000.00
  • ALSN $3,204,000,000.00
  • Revenue This Year
  • NBIX $26.97
  • ALSN $7.74
  • Revenue Next Year
  • NBIX $16.69
  • ALSN $4.13
  • P/E Ratio
  • NBIX $31.50
  • ALSN $14.19
  • Revenue Growth
  • NBIX 25.72
  • ALSN 7.59
  • 52 Week Low
  • NBIX $108.14
  • ALSN $53.00
  • 52 Week High
  • NBIX $157.98
  • ALSN $121.37
  • Technical
  • Relative Strength Index (RSI)
  • NBIX 42.69
  • ALSN 69.10
  • Support Level
  • NBIX $119.08
  • ALSN $117.98
  • Resistance Level
  • NBIX $129.67
  • ALSN $120.62
  • Average True Range (ATR)
  • NBIX 3.34
  • ALSN 2.52
  • MACD
  • NBIX -0.02
  • ALSN 0.50
  • Stochastic Oscillator
  • NBIX 14.59
  • ALSN 77.00

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

About ALSN Allison Transmission Holdings Inc.

Allison Transmission is the largest manufacturer of fully automatic transmissions for commercial vehicles. The company's automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business has about 60% global market share. The company's transmissions can be found in Class 4-8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motor homes). Allison also produces electric hybrid propulsion systems and is developing e-powertrains.

Share on Social Networks: